New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2013
08:06 EDTBDXBecton Dickinson receives FDA clearance to market BD MAX StaphSR assay
BD Diagnostics, a segment of Becton Dickinson, announced it has received FDA clearance to market the BD MAX StaphSR Assay for use on the fully-automated BD MAX System. The assay, with eXTended Detection Technology, detects Staphylococcus aureus and methicillin-resistant Staphylococcus aureus DNA directly from nasal swabs, including mecA dropout mutants and new strains of MRSA that may not be detected by other assays.
News For BDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 26, 2015
09:20 EDTBDXFluidigm has negative read through from Becton Dickinson deal, says Leerink
Subscribe for More Information
August 25, 2015
16:09 EDTBDXBecton Dickinson unit acquires Cellular Research to develop genomics platform
Subscribe for More Information
07:29 EDTBDXBecton Dickinson acquisition positive, says Stifel
Subscribe for More Information
August 19, 2015
06:08 EDTBDXFDA warns 'do not use' compounded drugs stored in BD 3ml, 5ml syringes
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use